Evaluation of the Analgesic Effect of 0.1% Indomethacin Solution on Corneal Abrasions

Purpose: The authors wished to verify the analgesic action of 0.1% indomethacin in a water-based solution on patients affected by traumatic corneal abrasions. Methods: 347 patients affected by traumatic corneal abrasions, having been randomly divided into 2 groups on the basis of the administration of indomethacin, were evaluated at 30 min, 12 h and 24 h after the initial treatment of the abrasion. The level of pain experienced was evaluated on a verbal pain scale and the healing time was evaluated relative to the dimension of the abrasion. Results: The pain level was initially overwhelming for both groups: p = 0.737; at successive check-ups it was possible to verify a reduction of the symptomatology, with a more pronounced decrease in pain in the group treated with indomethacin (p < 0.0001), which also demonstrated a lower sensitivity to pain in the case of larger lesions (p < 0.0001). There was no difference in the healing time between groups, and the reduction of pain is not correlated with corneal anesthesia and healing time. Conclusions: Our study highlighted the efficacy of indomethacin as a pain reducer for acute corneal pathology and suggested that the medication may act on the corneal nociceptors in a qualitative way.

[1]  J. Arne,et al.  A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. , 1998, Ophthalmic surgery and lasers.

[2]  J. Vane,et al.  Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs , 1997, British journal of pharmacology.

[3]  P. Reeh,et al.  Topical acetylsalicylic, salicylic acid and indomethacin suppress pain from experimental tissue acidosis in human skin , 1995, Pain.

[4]  A. Cohen,et al.  Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions. , 1995, Ophthalmology.

[5]  X. F. Huang,et al.  Central mechanism of indomethacin analgesia. , 1994, European journal of pharmacology.

[6]  P. McDonnell,et al.  Arachidonic acid metabolites after excimer laser corneal surgery. , 1993, Archives of ophthalmology.

[7]  R. Hoffman,et al.  Topical diclofenac reduces pain following photorefractive keratectomy. , 1993, Archives of ophthalmology.

[8]  L. Girard The effect of topical administration of indomethacin on symptoms in corneal scars and edema. , 1992, American journal of ophthalmology.

[9]  A. Rosenthal,et al.  One year in an eye casualty clinic. , 1985, The British journal of ophthalmology.

[10]  D. Price,et al.  The validation of visual analogue scales as ratio scale measures for chronic and experimental pain , 1983, Pain.

[11]  S. Linton,et al.  A clinical comparison of two pain scales: Correlation, remembering chronic pain and a measure of compliance , 1983, Pain.

[12]  K. Pasiecznik,et al.  In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae and Pseudomonas aeruginosa to Netilmicin and Selected Aminoglycoside Antibiotics , 1976, Antimicrobial Agents and Chemotherapy.

[13]  H. Bazan The synthesis and effects of eicosanoids in avascular ocular tissues. , 1989, Progress in clinical and biological research.

[14]  P. Laibson,et al.  Corneal ulcers related to contact lens use. , 1986, International ophthalmology clinics.